Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Aurobindo Pharma gets US FDA nod for generic osteoporosis drug

The company said the approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly.

Under the service, people can visit Common Service Centres (CSC) and fix an appointment for seeking expert consultancy with a doctor.
All the drugs being recalled by the company have been manufactured at its Mumbai-based facility and distributed in the US by its subsidiary, Wockhardt USA
The Indian drug firms have joined the global fight against antibiotic-resistant bacteria. The good news is that they are steadily moving ahead.
The firm's research arm - Sun Pharma Advanced Research Company - is currently working on three new drugs that are currently under clinical trial stage.